» Articles » PMID: 12549928

Cell Surface Heparan Sulfate Participates in CXCL1-induced Signaling

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2003 Jan 29
PMID 12549928
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The CXC subfamily of chemokines plays an important role in diverse processes, including inflammation, wound healing, growth regulation, angiogenesis, and tumorigenesis. The ELR-CXC chemokine, CXCL1 or MGSA/GROalpha, is traditionally considered to attract neutrophils to sites of inflammation. The non-ELR-CXC chemokine, CXCL10 or IP-10, is chemotactic for monocytes, B cells, and activated T lymphocytes. In addition to its role in leukocyte migration, CXCL10 inhibits the angiogenic functions of the ELR-CXC chemokines as well as bFGF and VEGF. Heparan sulfate proteoglycans (HSPGs) are required for the interaction of bFGF and vEGF ligands and their receptors. However, the role of HSPGs in regulating the ELR-chemokines signaling and biological functions is poorly understood. We show here that the CXCL1 maximal binding to CXCR2 expressed on HEK293 and CHO-K1 cells is dependent on the presence of cell surface HSPGs. The cell surface HSPGs on cells are required for CXCL1-induced PAK1 activation. Moreover, CXCL10 can inhibit CXCL1-induced PAK1 and ERK activation as well as the CXCL1-induced chemotaxis through decreasing CXCL1 binding to cell surface heparan sulfate. These data indicate that HSPGs are involved in modulating CXCL1-induced PAK1 activation and chemotaxis through regulating CXCL1 binding activity to CXCR2 receptor. CXCL10 inhibits CXCL1-induced PAK1 activation and chemotaxis by interfering with appropriate binding of CXCL1 to CXCR2 receptor.

Citing Articles

Deciphering the role of glycosaminoglycans in GPCR signaling.

Savransky S, White A, Vilardaga J Cell Signal. 2024; 118:111149.

PMID: 38522808 PMC: 10999332. DOI: 10.1016/j.cellsig.2024.111149.


A stretchable wireless wearable bioelectronic system for multiplexed monitoring and combination treatment of infected chronic wounds.

Sani E, Xu C, Wang C, Song Y, Min J, Tu J Sci Adv. 2023; 9(12):eadf7388.

PMID: 36961905 PMC: 10038347. DOI: 10.1126/sciadv.adf7388.


Heparan sulfates and heparan sulfate binding proteins in sepsis.

Liao Y, Liu J, Arnold K Front Mol Biosci. 2023; 10:1146685.

PMID: 36865384 PMC: 9971734. DOI: 10.3389/fmolb.2023.1146685.


: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space.

Korbecki J, Barczak K, Gutowska I, Chlubek D, Baranowska-Bosiacka I Int J Mol Sci. 2022; 23(2).

PMID: 35054978 PMC: 8776070. DOI: 10.3390/ijms23020792.


Overcoming the inhibitory microenvironment surrounding oligodendrocyte progenitor cells following experimental demyelination.

Saraswat D, Shayya H, Polanco J, Tripathi A, Welliver R, Pol S Nat Commun. 2021; 12(1):1923.

PMID: 33772011 PMC: 7998003. DOI: 10.1038/s41467-021-22263-4.


References
1.
Tanaka Y, Adams D, Shaw S . Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993; 14(3):111-5. DOI: 10.1016/0167-5699(93)90209-4. View

2.
Nickoloff B, Mitra R, Varani J, Dixit V, Polverini P . Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol. 1994; 144(4):820-8. PMC: 1887235. View

3.
Clark-Lewis I, DEWALD B, Geiser T, Moser B, Baggiolini M . Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci U S A. 1993; 90(8):3574-7. PMC: 46343. DOI: 10.1073/pnas.90.8.3574. View

4.
Manser E, Leung T, Salihuddin H, Zhao Z, Lim L . A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature. 1994; 367(6458):40-6. DOI: 10.1038/367040a0. View

5.
Moser B, DEWALD B, Barella L, Schumacher C, Baggiolini M, Clark-Lewis I . Interleukin-8 antagonists generated by N-terminal modification. J Biol Chem. 1993; 268(10):7125-8. View